Peter Collum

Director of Finance/CFO at REDX PHARMA PLC

Net worth: 29 040 $ as of 2024-04-29

Health Technology

Finance

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Joshua Schafer	M	53	PHARNEXT SCA	4 years
James Robert Mead	M	46	REDX PHARMA PLC	6 years
Andrew Booth	M	-	REDX PHARMA PLC	9 years
Peter Presland	M	75	REDX PHARMA PLC	7 years
Monica Lozano	F	67	MERRILL LYNCH PREFERRED CAPITAL TRUST I	18 years
Lawrence Steinman	M	76	PHARNEXT SCA	4 years
Bernhard Kirschbaum	M	65	REDX PHARMA PLC	8 years
Christine Katziff	F	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	20 years
Dennis M. Conroy	M	52	MTS Health Partners LP MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY.	11 years
Lisa Anson	F	-	REDX PHARMA PLC	6 years
Robert Scott	M	70	REDX PHARMA PLC	2 years
Natalie Berner	F	34	REDX PHARMA PLC	3 years
Toru Kobayashi	M	-	MTS Health Partners LP MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY.	7 years
Evan R. Bernstein	M	-	MTS Health Partners LP MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY.	13 years
Nischal Hindia	M	-	REDX PHARMA PLC	-
Lucy DaRita-Oppenhim	F	-	MTS Health Partners LP MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY.	13 years
Caitlin Pearson	F	-	REDX PHARMA PLC	2 years
Anamaria Sudarov	M	-	MTS Health Partners LP MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY.	8 years
Geoffrey Greener	M	59	MERRILL LYNCH PREFERRED CAPITAL TRUST I	17 years
Jane Griffiths	M	69	REDX PHARMA PLC	3 years
Richard E. Armer	M	-	REDX PHARMA PLC	12 years
Kazuki Kusaka	M	-	MTS Health Partners LP MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY.	6 years
Joseph Anderson	M	65	REDX PHARMA PLC	1 years
Gottlieb A. Keller	M	70	Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	28 years
Melissa Israel	F	-	PHARNEXT SCA	4 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Thomas May	M	77	MERRILL LYNCH PREFERRED CAPITAL TRUST I	18 years
Daniel Cohen	M	-	PHARNEXT SCA	13 years
Meghan Kearns Danaher	F	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	9 years
Neil A. Cotty	M	70	MERRILL LYNCH PREFERRED CAPITAL TRUST I	12 years
Alvaro de Molina	M	66	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Iain Ross	M	71	REDX PHARMA PLC	4 years
David Stout	M	70	PHARNEXT SCA	2 years
Sanjay Gupta	M	55	MERRILL LYNCH PREFERRED CAPITAL TRUST I	7 years
Roger Taylor	M	76	MERRILL LYNCH PREFERRED CAPITAL TRUST I	39 years
Holly Ruxin	F	54	MERRILL LYNCH PREFERRED CAPITAL TRUST I	5 years
Stacey Goodman	F	61	MERRILL LYNCH PREFERRED CAPITAL TRUST I	6 years
Amanda Norton	M	58	MERRILL LYNCH PREFERRED CAPITAL TRUST I	14 years
Kathy Ordoñez	F	73	Hoffmann-La Roche, Inc. Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.	15 years
Samuel T. Ramsey	M	64	MERRILL LYNCH PREFERRED CAPITAL TRUST I	1 years
David Solomon	M	63	PHARNEXT SCA	2 years
Lena Elisabeth Svanberg	M	63	PHARNEXT SCA	2 years
Jeff Carlson	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	4 years
Virgis Colbert	M	84	MERRILL LYNCH PREFERRED CAPITAL TRUST I	7 years
Sarah Gordon-Wild	F	-	REDX PHARMA PLC	3 years
James Hance	M	79	MERRILL LYNCH PREFERRED CAPITAL TRUST I	17 years
Charles W. Coker	M	90	MERRILL LYNCH PREFERRED CAPITAL TRUST I	37 years
Claire Solk	F	-	REDX PHARMA PLC	-
David A. Rozenson	M	69	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Anne Finucane	F	71	MERRILL LYNCH PREFERRED CAPITAL TRUST I	16 years
Marc Oken	M	77	MERRILL LYNCH PREFERRED CAPITAL TRUST I	16 years
Frank P. Bramble	M	75	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Ann Snelling Gluse	F	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	4 years
John Lawrence Sica	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Jerrid Jemal Douglas	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Martin William Courage	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	7 years
Robert L. Tillman	M	80	MERRILL LYNCH PREFERRED CAPITAL TRUST I	4 years
Lorie K. Rupp	F	59	MERRILL LYNCH PREFERRED CAPITAL TRUST I	18 years
Virgil R. Williams	M	85	MERRILL LYNCH PREFERRED CAPITAL TRUST I	8 years
Charles B. Bernicker	M	59	MERRILL LYNCH PREFERRED CAPITAL TRUST I	2 years
Rod Bolger	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	5 years
Tayfun Selen	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	4 years
Marcel Takeshi Abe	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	6 years
Ciaran O’Kelly	M	55	MERRILL LYNCH PREFERRED CAPITAL TRUST I	7 years
Jay Iseman	M	64	MERRILL LYNCH PREFERRED CAPITAL TRUST I	9 years
Mary Harman	F	54	MERRILL LYNCH PREFERRED CAPITAL TRUST I	12 years
Megan Frank	F	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	4 years
Zherebtsova Maria	F	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	3 years
Tracy Ongena	F	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	7 years
Vernau Charles	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	4 years
Gabriel Zynstein Korach	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	3 years
Roger Hill Manternach	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	34 years
Samuel Nag Tsien	M	70	MERRILL LYNCH PREFERRED CAPITAL TRUST I	11 years
John J. Witkowski	M	61	MERRILL LYNCH PREFERRED CAPITAL TRUST I	12 years
Raymond D. Vaughn	M	71	MERRILL LYNCH PREFERRED CAPITAL TRUST I	3 years
Anne Saunders	F	63	MERRILL LYNCH PREFERRED CAPITAL TRUST I	2 years
Richard C. DiChiara	M	73	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Bob M. Zakem	M	66	MERRILL LYNCH PREFERRED CAPITAL TRUST I	2 years
Kathleen Foley Feldstein	M	83	MERRILL LYNCH PREFERRED CAPITAL TRUST I	6 years
Willis Dowd	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
William Barnet	M	81	MERRILL LYNCH PREFERRED CAPITAL TRUST I	5 years
Richard DeMartini	M	71	MERRILL LYNCH PREFERRED CAPITAL TRUST I	3 years
Theo Dickens	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	5 years
Joseph Zavaglia	M	75	MERRILL LYNCH PREFERRED CAPITAL TRUST I	28 years
Timothy G. Henry	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Karin Hirtler-Garvey	F	67	MERRILL LYNCH PREFERRED CAPITAL TRUST I	10 years
John L. Morton	M	79	MERRILL LYNCH PREFERRED CAPITAL TRUST I	9 years
Robert Nagy	M	63	MERRILL LYNCH PREFERRED CAPITAL TRUST I	10 years
Lora Baldwin	F	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Rohail A. Khan	M	57	MERRILL LYNCH PREFERRED CAPITAL TRUST I	2 years
Brad Dorman	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Micheal Hargrave	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Eduardo Villalobos	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	5 years
James T. Herold	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	6 years
Charles Stephen McMillan	M	77	MERRILL LYNCH PREFERRED CAPITAL TRUST I	4 years
Edward P. O'Keefe	M	68	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
Nicholas O'Leary	M	41	MERRILL LYNCH PREFERRED CAPITAL TRUST I	3 years
R. Bruce Singletary	M	73	MERRILL LYNCH PREFERRED CAPITAL TRUST I	-
George C. Hansen	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	6 years
Bonnie Baker	F	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	5 years
Paul Tuan	M	-	MERRILL LYNCH PREFERRED CAPITAL TRUST I	2 years

Statistics

Country	Connections	% of total
United States	78	78.00%
United Kingdom	15	15.00%
France	7	7.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections